Feed Preview

Autoimmune Lymphoproliferative Syndrome

Autoimmune Lymphoproliferative Syndrome diagram by undefined

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Top 20 most recent papers

Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis

NatureSeptember 13, 2019
Kim NewtonVishva M. Dixit
The Journal of Clinical Investigation

Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease

The Journal of Clinical InvestigationNovember 5, 2019
Juan C RavellMichael J. Lenardo

Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study

BloodOctober 2, 2019
Carlo ViscoMarco Ruggeri
Clinical Nuclear Medicine

18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome

Clinical Nuclear MedicineOctober 23, 2019
Jorge A CarrasquilloV. Koneti Rao
Clinical Nuclear Medicine

18F-FDG PET Imaging Features of Patients With Autoimmune Lymphoproliferative Syndrome

Clinical Nuclear MedicineNovember 7, 2019
Jorge A CarrasquilloV. Koneti Rao
Autoimmunity Reviews

Monogenic lupus: Dissecting heterogeneity

Autoimmunity ReviewsAugust 12, 2019
Ommar OmarjeeAlexandre Belot
British Journal of Haematology

FAS-mediated apoptosis impairment in patients with ALPS/ALPS-like phenotype carrying variants on CASP10 gene

British Journal of HaematologyJuly 17, 2019
Maurizio MianoFrancesca Fioredda
The British Journal of Dermatology

Persistence of anti-envoplakin and anti-periplakin antibodies in a case of Paraneoplastic Pemphigus 20 years after remission

The British Journal of DermatologySeptember 16, 2019
José Riera-MonroigJosé Manuel Mascaró
Frontiers in Immunology

Corrigendum: Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)

Frontiers in ImmunologyJuly 4, 2019
Andrea LiscoIrini Sereti
Journal of Clinical Immunology

A Spectrum of Clinical Findings from ALPS to CVID: Several Novel LRBA Defects

Journal of Clinical ImmunologyAugust 22, 2019
Deniz ÇağdaşIlhan Tezcan
Nature Communications

Fas signaling-mediated TH 9 cell differentiation favors bowel inflammation and antitumor functions

Nature CommunicationsJuly 2, 2019
Ying-Ying ShenJian-Li Wang
Frontiers in Immunology

Glucocorticoids-All-Rounders Tackling the Versatile Players of the Immune System

Frontiers in ImmunologyJuly 24, 2019
Cindy StrehlFrank Buttgereit
Journal of Autoimmunity

New insights in cryoglobulinemic vasculitis

Journal of AutoimmunityAugust 2, 2019
Filipa SilvaJorge Almeida
Scientific Reports

A full-width half-maximum method to assess retinal vascular structural changes in patients with ischemic heart disease and microvascular anginga

Scientific ReportsJuly 29, 2019
Bo Lun XuYu Hua Tong
Expert Review of Clinical Immunology

Malignancy in common variable immunodeficiency: a systematic review and meta-analysis

Expert Review of Clinical ImmunologyAugust 28, 2019
Fatemeh KiaeeAsghar Aghamohammadi
Seminars in Neurology

Central Nervous System Opportunistic Infections

Seminars in NeurologyJune 1, 2019
Shruti P Agnihotri

Recurrent anti-GBM disease with T-cell large granular lymphocytic leukemia: A case report

MedicineAugust 1, 2019
Min ZhangJun Xue
Endocrine, Metabolic & Immune Disorders Drug Targets

Diagnostic Approach to The Patients with Suspected Primary Immunodeficiency

Endocrine, Metabolic & Immune Disorders Drug TargetsAugust 28, 2019
Marzieh TavakolAsghar Aghamohammadi
Clinical Kidney Journal

Predictive factors of renal involvement in cryoglobulinaemia: a retrospective study of 153 patients

Clinical Kidney JournalJune 1, 2019
Vladimir ColicheFouque Denis
Pediatric Rheumatology Online Journal

RAS-associated Autoimmune Leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children

Pediatric Rheumatology Online JournalAugust 14, 2019
Wei WangHong-Mei Song

See more papers from this feed

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

© 2019 Meta ULC. All rights reserved